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The intervening domain from 
MeCP2 enhances the DNA affinity 
of the methyl binding domain and 
provides an independent DNA 
interaction site
Rafael Claveria-Gimeno1,2,3, Pilar M. Lanuza1,3,4, Ignacio Morales-Chueca1,2, Olga C. Jorge-Torres5, 
Sonia Vega1, Olga Abian1,2,3,4,6, Manel Esteller5,7,8 & Adrian Velazquez-Campoy1,3,4,9
Methyl-CpG binding protein 2 (MeCP2) preferentially interacts with methylated DNA and it is 
involved in epigenetic regulation and chromatin remodelling. Mutations in MeCP2 are linked to Rett 
syndrome, the leading cause of intellectual retardation in girls and causing mental, motor and growth 
impairment. Unstructured regions in MeCP2 provide the plasticity for establishing interactions with 
multiple binding partners. We present a biophysical characterization of the methyl binding domain 
(MBD) from MeCP2 reporting the contribution of flanking domains to its structural stability and dsDNA 
interaction. The flanking disordered intervening domain (ID) increased the structural stability of 
MBD, modified its dsDNA binding profile from an entropically-driven moderate-affinity binding to an 
overwhelmingly enthalpically-driven high-affinity binding. Additionally, ID provided an additional site 
for simultaneously and autonomously binding an independent dsDNA molecule, which is a key feature 
linked to the chromatin remodelling and looping activity of MeCP2, as well as its ability to interact with 
nucleosomes replacing histone H1. The dsDNA interaction is characterized by an unusually large heat 
capacity linked to a cluster of water molecules trapped within the binding interface. The dynamics of 
disordered regions together with extrinsic factors are key determinants of MeCP2 global structural 
properties and functional capabilities.
Among the thousands of proteins encoded in the human genome 30% of them are completely or partially devoid 
of stable structure1,2. These intrinsically disordered proteins (IDPs) are characterized by a global or local lack of 
secondary and tertiary structure, and they may undergo a structural rearrangement upon the interaction with 
their binding partners. This structural plasticity allows them to interact with a large variety of physiological part-
ners (in fact, many IDPs are important hubs in protein interaction networks), adapting their conformation to 
different structural scaffolds. The presence of flexible regions facilitates structural rearrangements necessary for 
exposing different binding motifs and for allosteric regulation of binding partners. On the other hand, these inter-
actions are characterized by a moderate-to-low binding affinity and a transient nature, because of the energetic 
penalty stemming from the conformational change required for the binding.
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The structural effect of disordered regions in proteins is controversial. Intrinsically disordered regions have a 
priori unknown roles in molecular stability and function. While these regions are characterized by a biased resi-
due composition, where polar and charged residues predominate and they exhibit a considerable propensity to be 
exposed to the solvent3, they still can make key contacts with structured regions and affect the global stability and 
the dynamics of the protein, as well as modulate the interaction with a binding partner. The impact of disordered 
regions on the global stability can be exerted through specific or unspecific effects. Specific effects may derive 
from long-lived or transient interactions between residues from disordered and structured regions, while unspe-
cific effects may be due to reciprocal constrained flexibility/mobility of the polypeptide chain because of steric 
hindrance. Long-range electrostatic and dipolar interactions are extremely important in IDPs, especially at low 
ionic strength, because of the large fraction of charged and polar residues.
Prediction of IDP regions is usually made on the basis of the local structural and physico-chemical properties 
of the polypeptide chain4. Though these algorithms are quite robust, they may overestimate the extent of the dis-
ordered region5. On the other hand, there are many experimental techniques providing information about con-
formational changes coupled to binding interactions. Some of them provide structural information at an atomic 
(e.g. nuclear magnetic resonance) or molecular level (e.g. small-angle x-ray scattering), while some other provide 
detailed energetic information at a molecular level (e.g. isothermal titration calorimetry, ITC) compared to other 
less informative techniques. In particular, among other advantages, ITC allows the best estimation of the binding 
enthalpy, the binding stoichiometry, the heat capacity change upon binding, as well as the assessment of proton 
exchange events (or other additional equilibria) coupled to the binding interaction. Therefore, ITC provides the 
complete thermodynamic profile for any intermolecular interaction, from which valuable information can be 
extracted regarding the key structural and energetic determinants of such interaction.
Transcription regulation and chromatin architecture remodelling are two very complex processes tightly con-
trolled by a huge number of proteins and epigenetic modifications, where slight alterations in the DNA or the 
proteins involved may result in disease. Rett syndrome (RTT) is an example of dysregulation of transcription and 
chromatin structure with severe consequences on neuronal development, differentiation and maturation. RTT 
is a disorder affecting 1/10000 live births. Although considered a rare disease, RTT is the main cause of mental 
retardation in females, characterized by a clinically varied expression and sharing features with other neurolog-
ical autistic diseases. De novo mutations in the gene encoding Methyl-CpG binding Protein 2 (MeCP2) associ-
ated with an altered, defective MeCP2 protein (regarding its structural stability and folding, or its interaction 
with DNA and RNA or other protein partners) are involved in disease development6,7. MeCP2 is an IDP organ-
ized into six domains: N-terminal domain (NTD), methyl binding domain (MBD), intervening domain (ID), 
transcriptional repression domain (TRD), C-terminal domain α (CTDα ), and C-terminal domain β (CTDβ ) 
(Supplementary Fig. S1)8,9. In principle, the most important domains are MBD and TRD, initially associated with 
methylated CpG (mCpG) DNA binding or transcription repressor activities10,11 and the location for most of the 
mutations associated with RTT. However, it has been shown that other domains (ID, CTDα and CTDβ ) are also 
directly or indirectly involved in methyl-independent DNA interaction9,12.
MBD is the best characterized domain in MeCP2 and its structure has been determined either free in solu-
tion or bound to mCpG-DNA13,14. Although there are some differences between these two structures, the 
wedge-shaped structured core can be described as a 3-stranded anti-parallel β -sheets with an α -helix on the 
C-terminal side. Flanking this core, two unstructured regions are found. Binding to DNA has been shown to 
increase MBD secondary structure. MBD is considered to be directly involved in maintaining full-MeCP2 organ-
ization through interactions with other domains. Therefore, it has been proposed to be the core of the protein 
structure as it would drive interdomain coupling, and mutations on this domain would impact on its own and 
global stability and function8.
Several mechanisms of action and interaction partners have been described for the MeCP2. MBD has been 
shown to provide strong selectivity through symmetrically methylated DNA duplex both in vitro and in vivo, 
modulated by environmental factors (in particular, ionic strength). In addition, MeCP2 has revealed broad dis-
tribution tracking the density of 5-methyl-cytidines, being especially abundant in the heterochromatin foci15. 
MeCP2 can also bind non-specifically to unmethylated DNA. Although this interaction shows lower affinity, that 
is not a large enough difference to explain its preferential distribution. Thus, it has been proposed that methyl-
ation density could modulate the specificity16. Similar to histone H1, MeCP2 is a chromatin-compacting factor 
in a methylation-independent manner17. Lack of MeCP2 results in a disorganized chromatin structure lead-
ing to impairment of synaptic plasticity derived from improper neuronal responses to stimuli. This represents a 
genome-wide, unspecific repressive activity, different from the specific repressor role associated with methylated 
DNA. Therefore, besides regulating the expression of specific genes, MeCP2 can act globally as a histone-like 
component organizing chromatin into a highly specialized organization18,19. Inverse correlation in MeCP2 and 
histone H1 levels, as well as their competitive binding to nucleosomes, indicates a compensatory mechanism 
between MeCP2 and histone H1 and points to a genome-wide function for MeCP2 with an architectural role 
similar to that of H118. MeCP2 interacts with four potential nucleosomal binding targets: the free linker DNA 
through histone H1 displacement, the curved DNA wrapped around the nucleosome, the protein surface of the 
nucleosome, and the solvent exposed core histone N-terminal tail domains16,20. On the other hand MeCP2 inter-
acts with other proteins involved in gene regulation, either co-repressors (e.g., mSin3A, cSki co-REST, NcoR/
SMRT) for which the disruption of their interactions caused by RTT-associated mutations is a key element for 
understanding the pathology21,22, transcription factors (e.g., YY1) or activators (e.g., CREB)15,23, and it also inter-
acts with RNA through an RNA-binding RG repeat region and regulates gene expression at a different level24.
These activities are related to different biological roles. MeCP2 is involved in gene regulation associated with 
either gene silencing or activation25. Several mechanisms are associated to this event, which is important for bio-
logical aspects such as decreasing transcriptional noise or adapting gene expression pattern to different physio-
logical or environmentally-induced conditions26. In addition, MeCP2 acts as a chromatin architecture remodeller 
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through interactions with nucleosomes, maintaining and reshaping local and global chromatin structures associ-
ated with gene expression regulation. Finally, MeCP2 participates in gene regulation at RNA level by interacting 
with RNA transcripts and RNA-binding proteins (e.g., YB1)27.
MeCP2 is a multifaceted protein where its structural and energetic properties must be intimately connected 
to its great variety of biological roles. The aim in this work is to reveal how some structural and double-stranded 
DNA (dsDNA) interaction properties provide the basis for some of these roles at a molecular level. In particular, 
the goal is twofold:
•	 To describe in detail the effect of flanking domains, NTD and ID, on the structural stability of MBD at low 
ionic strength. This has been done previously at high ionic strength12,28. However, it has been reported that 
the ability to discriminate between methylated and unmethylated dsDNA depends on ionic strength, among 
other factors29. Moreover, a highly polar, basic, disordered protein such as MeCP2 must be highly susceptible 
to its environment, especially at low ionic concentration where long-range electrostatic interactions may play 
a major role.
•	 To provide, for the first time, the complete thermodynamic profile of the interaction of MBD with dsDNA, 
assessing the role of the flanking domains (NTD and ID), as well as the effect of extrinsic factors such as the 
ionic concentration and the sequestering of water molecules within the polar protein-DNA interface14.
Results
Structural analysis of MeCP2 and variants. Far-UV CD spectra of MBD exhibited two regions 
typical from β -sheet and random-coil (centered around 208 nm) and α -helix (centered around 222 nm) 
(Supplementary Fig. S2), in agreement with the solution structure obtained by NMR (PDB code 1qk9) and the 
crystallographic structure obtained by x-ray diffraction (PDB code 3c2i)13,14. MBD is largely unstructured and, 
therefore, the intensity of the CD signal is small, as well as its change with temperature. Nonetheless, a small loss 
of secondary structure upon thermal denaturation could be observed. As expected, the far-UV spectra of the 
variants were similar in shape, but exhibited a lower intensity when normalized by the number of residues, indi-
cating that the flanking domains are disordered. Differential scanning calorimetry experiments showed the same 
difficulties: the small structured core in MBD is associated to a low stability and a small molar unfolding enthalpy 
(low unfolding cooperativity), leading to a very small experimental signal. Increasing the protein concentration 
is impractical because MBD is prone to aggregation at high concentration.
Fluorescence spectra monitoring the intrinsic fluorescence intensity of the single tryptophan residue in MBD 
(W104, Fig. 1) were employed to overcome the difficulties found in circular dichroism and differential scanning 
calorimetry. At low temperature MBD showed typical asymmetric bell-shaped spectra, indicating that the tryp-
tophan residue is not solvent-exposed as observed in the NMR and crystallographic structures. A temperature 
increase caused a dramatic reduction in fluorescence intensity and a red-shift towards higher wavelengths (the 
wavelength for maximal intensity changed from 330 nm to 350 nm), due to dynamic water quenching of trypto-
phan fluorescence intensity when exposed to the solvent upon unfolding (Fig. 1). From a set of emission spectra 
in the temperature range 10–90 °C, the emission wavelength for the maximal spectral change was estimated to be 
330 nm. The same behavior was observed with the variants.
Thermal unfolding of MBD and variants. Thermal unfolding assays for MBD and its variants were per-
formed by recording the fluorescence emission intensity at a fixed wavelength (330 nm) as a function of temper-
ature (Fig. 1). Non-linear fitting assuming a two-state unfolding model allowed estimating the thermodynamic 
parameters that define the stability of MBD and its variants: midtransition temperature, Tm, and unfolding 
enthalpy, Δ H(Tm) (Table 1). Because thermal denaturations are rather insensitive to unfolding heat capacity 
values, Δ CP, an estimated value of 0.5 kcal/K·mol was employed according to published correlations between 
structural and energetic parameters30 and the known percentage of structure in MBD (60%)12; the excellent fits 
for the unfolding transitions validated that election. Reversibility tests confirmed the unfolding is fully reversi-
ble. In addition, the agreement with preliminary unfolding experiments using circular dichroism confirmed the 
applicability of the two-state unfolding model.
For MBD the Tm decreased with pH and increased with ionic strength, while the unfolding enthalpy (related 
to the folding/unfolding cooperativity level) did not change significantly. In general, if the stability of a protein 
increases (decreases) with the concentration of a co-solute, then, the folded (unfolded) state preferentially inter-
acts with that co-solute. The following equation summarizes this phenomenon31,32:
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where Kunf,obs is the equilibrium constant for the unfolding process, S is the co-solute, and Δ nS is the net num-
ber of co-solute molecules exchanged upon unfolding (positive for uptake or preferential interaction with the 
unfolded conformation, negative for release or preferential interaction with the native conformation). Assuming 
some approximations the following equation is obtained from equation (1)32,33:
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which can be employed to roughly estimate the number of co-solute molecules exchanged upon unfolding. 
Accordingly, the dependency of the stability with pH and ionic strength indicates that the unfolding process is 
coupled with the preferential interaction of protons and salt ions with either the folded or the unfolded confor-
mations of MBD. Thus, because the stability of MBD decreases with increasing the pH (lowering concentration 
of protons), the folded MBD interacts preferentially with protons and its unfolding is coupled to the release of 
protons (that is, the unfolded MBD gets deprotonated, compared to the folded MBD). Similarly, because the 
stability of MBD increases with increasing the salt concentration, the folded MBD interacts preferentially with 
salt ions and the unfolding is coupled to the release of salt ions. In addition, salt ions may have an additional 
charge-screening effect and contribute to the increase stability at high ionic strength by diminishing repulsive 
interactions between positively charged groups. From the results in Table 1 and equation (1) it can be estimated 
that approximately − 0.3 protons and − 0.7 salt ions are released upon MBD unfolding. A rather similar behavior 
regarding the pH and ionic strength dependency was observed with the variants (Table 1).
The most striking result is that, at any pH and ionic strength, the structural stability (in terms of Tm, and 
Δ H(Tm)) gradually increased with the addition of the disordered domains NTD and ID. For example, at pH 7, the 
addition of NTD and ID increased the Tm in 2.3 °C and 7.8 °C, respectively. Therefore, those disordered regions 
contribute significantly, through specific or unspecific effects, to the structural stability of the molecule.
dsDNA-induced stabilization effect on MeCP2 MBD and variants. The interaction of MBD and 
its variants with its physiological ligand was indirectly monitored by assessing the stabilizing effect induced by 
methylated and unmethylated dsDNA. As it has been indicated above, preferential interaction of a solute with 
the native conformation leads to stabilization of such conformation (equations (1) and (2)), which in practice can 
be observed as stabilization against thermal denaturation (increase in Tm and Δ H(Tm)). Thermal denaturations 
were performed for MBD and its variants in the presence of unmethylated and mCpG dsDNA corresponding to 
the BDNF promoter region IV (Fig. 1), employing the same protocol used for the DNA-free proteins. The thermal 
denaturation curves were fitted using the two-state unfolding model and the apparent thermodynamic parame-
ters for the unfolding of the protein-DNA complex were estimated.
In all cases dsDNA increased the stability of MBD, as observed in the values in Tm and Δ H(Tm) compared 
to those for the dsDNA-free MBD, at each experimental condition (Fig. 1, Table 1). This is an indication of 
Figure 1. Structural features and thermal stability of the MeCP2 MBD. (A,B) Solution structure of MBD 
(pdb 1qk9) and crystallographic structure of MBD bound to mCpG-dsDNA (pdb 3c2i) showing the tryptophan 
104 within the folding core. (C) Fluorescence spectra recorded at different temperatures showing the large 
quantum yield of the single tryptophan at low temperature and the substantial dynamic quenching by water 
molecules upon unfolding. (D) Fluorescence thermal denaturations for MBD, NTD-MBD and NTD-MBD-ID 
in the absence of dsDNA and in the presence of unmethylated and mCpG-dsDNA. All unfolding traces could be 
fitted considering a two-state unfolding model (not shown for clarity purposes). Figures have been created with 
PyMol (http://www.pymol.org/).
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preferential binding of dsDNA with the folded MBD, as expected. The same results were observed for the protein 
variants.
The extent of the ligand stabilization effect (i.e. increase in Tm, or Δ Tm) on MBD depends on the binding 
affinity, the binding stoichiometry, and the concentration of dsDNA. Because the concentration of dsDNA was 
the same in all these assays, one would expect the Δ Tm values to be useful to rank binding affinities for different 
ligands (i.e., the larger the Δ Tm value, the higher the protein-dsDNA binding affinity). However, this is not the 
usual case, since the binding enthalpy and the binding heat capacity, which might be different for each ligand, 
also modulate the extent of the ligand-induced stabilization effect. In addition, domain ID can also interact with 
dsDNA12, leading to further stabilization of the native protein conformation.
Methylated dsDNA caused a stabilization effect on MBD larger than that of unmethylated DNA (Fig. 1, 
Table 1), reflecting the preferential interaction or specificity of MBD towards methylated DNA. The same phe-
nomenon was observed for the variants including the flanking domains. Surprisingly, not only the flanking 
domains, NTD and ID, increase the thermal stability of dsDNA-free MBD, but they also enhance the stabilizing 
effect induced by the dsDNA binding. In fact, the stabilization effect of dsDNA on NTD-MBD-ID is much larger 
than that observed for the other proteins (Fig. 1, Table 1). The extent of the stabilization effect induced by dsDNA 
does not correlate with the measured binding affinities (see below), because there was very little difference in 
binding affinity between methylated and unmethylated dsDNA (see below). Very likely differences in the binding 
enthalpy and binding heat capacity might justify those distinctive different stabilization effects.
Interaction of MeCP2 MBD and variants with dsDNA. Previous to the calorimetric study of the inter-
action of MBD with dsDNA, ultracentrifugation experiments were carried out in order to get information about 
the binding stoichiometry. Sedimentation velocity experiments provided sedimentation coefficients of 3.3S, 0.8S 
and 4.0S for the dsDNA, MBD and MBD-dsDNA complex, respectively, in agreement with their molecular mass 
in solution (Supplementary Fig. S3). Therefore, our results indicate a 1:1 protein:dsDNA binding stoichiometry 
for a 45 bp dsDNA fragment, as reported previously10, although a 2:1 protein:dsDNA stoichiometry has also been 
reported26.
The interaction of MBD and its variants with dsDNA was directly assessed by ITC. For the binding of 
MBD and NTD-MBD to dsDNA a model with a single binding site was considered, but for the binding of 
NTD-MBD-ID to dsDNA a model with two different binding sites had to be considered, since two distinguisha-
ble binding events could be clearly observed (see below).
The interaction between MBD and dsDNA was characterized by moderate affinity (dissociation constant in 
the submicromolar range), exhibiting an entropically driven binding with a binding enthalpy slightly unfavorable 
(Fig. 2, Table 2). Previous works reported higher affinities, but this can be reconciled considering the different 
experimental pH in our study. The interaction of MBD with dsDNA was coupled to the net release of 2 protons 
upon complex formation (therefore, at least two ionizable groups are involved in that proton exchange process) 
(Table 2). That means that increasing the pH in 0.5 units will increase the binding affinity 10-fold, resulting in 
a dissociation constant in fair agreement with published results12,29. In addition, the interaction of MBD with 
Tm (°C) ΔH(Tm) (kcal/mol) ΔTm b (°C)
MBD
pH 7 38.4 ± 0.3 29 ± 1
pH 8 36.9 ± 0.3 33 ± 1
pH 9 30.8 ± 0.3 27 ± 1
pH 7, NaCl 150 mM 46.4 ± 0.4 32 ± 1
unmethylated dsDNA 48.9 ± 0.3 38 ± 2 10.5 ± 0.4
methylated dsDNA 56.5 ± 0.3 44 ± 2 18.1 ± 0.4
NTD-MBD
pH 7 40.7 ± 0.2 33 ± 1 2.3 ± 0.4
pH 8 39.3 ± 0.2 31 ± 1 2.4 ± 0.4
pH 9 42.4 ± 0.2 34 ± 1 11.6 ± 0.4
pH 7, NaCl 150 mM 48.0 ± 0.2 33 ± 1 1.6 ± 0.4
unmethylated dsDNA 55.9 ± 0.2 42 ± 2 15.2 ± 0.3
methylated dsDNA 62.6 ± 0.2 48 ± 2 21.9 ± 0.3
NTD-MBD-ID
pH 7 46.2 ± 0.2 37 ± 1 7.8 ± 0.4
pH 8 45.9 ± 0.3 48 ± 3 9.0 ± 0.4
pH 9 45.4 ± 0.2 53 ± 2 14.6 ± 0.4
pH 7, NaCl 150 mM 49.8 ± 0.1 38 ± 1 3.4 ± 0.4
unmethylated dsDNA 66.9 ± 0.1 61 ± 2 20.7 ± 0.2
methylated dsDNA 71.2 ± 0.2 86 ± 4 25.0 ± 0.3
Table 1.  Unfolding stability parameters obtained from thermal denaturations followed by intrinsic 
tryptophan fluorescencea. Experiments in the presence of mCpG- and unmethylated dsDNA were performed 
at pH 7. aUnfolding stability parameters were estimated considering a two-state unfolding model. bDifferences 
in midtransition temperature, Δ Tm, are calculated taking as a reference the Tm of the MBD at the same 
experimental conditions or the same variant in the absence of dsDNA.
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dsDNA is characterized by a large, negative binding heat capacity (Fig. 2, Table 2). MBD shows just a 2-fold 
difference in binding affinity in favor of methylated dsDNA. This small difference in dsDNA selectivity towards 
methylated DNA has been observed previously29. The increase in ionic strength to NaCl 150 mM significantly 
affected the binding affinity (∼ 1000-fold decrease) and could not be reliably determined (Supplementary Fig. S4). 
This binding affinity reduction indicates that, according to the following relationship31,33:

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the formation of the complex is coupled to the release of approximately 4 salt ions from the complex (polyelectro-
lyte effect), in reasonable agreement with previously reported values29.
Addition of NTD to MBD did not change significantly the thermodynamic profile of the interaction with 
dsDNA (Fig. 3, Table 2). The only significant differences regarding MBD were: slightly higher binding affinity, a 
negligible binding enthalpy, and a slightly smaller binding heat capacity. Interestingly, the binding heat capacity 
for the binding of mCpG-dsDNA was always a bit smaller than that for the binding of unmethylated dsDNA.
Figure 2. MBD interaction with dsDNA. (A,B) Calorimetric titrations of MBD interacting with dsDNA in 
Tris 50 mM, pH 7, 20 °C. The upper plots show the thermogram (thermal power as a function of time), whereas 
the lower plots show the binding isotherm (normalized heats as a function of the dsDNA/protein molar ratio). 
(C) Experiments at different temperatures provided an estimation of the binding heat capacity. (D) Experiments 
using buffers with different ionization enthalpy provided an estimation of the buffer-independent binding 
enthalpy and the net number of exchanged protons upon MBD-dsDNA complex formation.
dsDNA Kda (nM) ΔGb (kcal/mol) ΔHc (kcal/mol) −TΔSd (kcal/mol) ΔCPe (kcal/K·mol) ΔnH c
MBD
unmethylated 450 − 8.5 0.8 − 9.3 − 2.3 − 2.4
methylated 240 − 8.9 1.5 − 10.4 − 1.9 − 2.1
NTD-
MBD
unmethylated 210 − 9.0 − 0.2 − 8.8 − 2.1 − 2.1
methylated 90 − 9.5 − 0.2 − 9.3 − 1.7 − 1.9
NTD-
MBD-
ID
unmethylated
1.9 − 11.7 − 54.6 42.9 − 2.7 − 0.1
250 − 8.9 − 7.6 − 1.3 − 0.96 − 2.9
methylated
0.56 − 12.4 − 48.4 36.0 − 2.2 − 0.1
62 − 9.7 − 2.1 − 7.6 − 0.92 − 1.3
Table 2.  Buffer-independent dsDNA binding parameters obtained from calorimetric titrations at pH 7. 
 aKd = (KB,obs)−1. bΔ G = RT lnKd. cΔ H and Δ nH were estimated by performing titrations using buffers with 
different ionization enthalpies and through linear regression using equation (8). dEntropic contribution 
was calculated according to: − TΔ S = Δ G − Δ H. eΔ CP was estimated by performing titrations at different 
temperatures and through linear regression using equation (6). Relative error in Kd is 10%; absolute errors in  
Δ G is 0.1 kcal/mol; absolute errors in Δ H, − TΔ S and Δ CP are 0.3 kcal/mol; and absolute error in Δ nH is 0.1.
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However the addition of ID changed completely the interaction, causing a dramatic increase in the bind-
ing affinity for dsDNA in MBD (dissociation constant changing from the submicromolar to the subnanomolar 
range), but it also provided an additional dsDNA binding site in ID (Fig. 4, Table 2). A preliminary analysis of the 
Figure 3. NTD-MBD interaction with dsDNA. (A,B) Calorimetric titrations of NTD-MBD interacting with 
dsDNA in Tris 50 mM, pH 7, 20 °C. The upper plots show the thermogram (thermal power as a function of 
time), whereas the lower plots show the binding isotherm (normalized heats as a function of the dsDNA/protein 
molar ratio). (C) Experiments at different temperatures provided an estimation of the binding heat capacity.  
(D) Experiments using buffers with different ionization enthalpy provided an estimation of the buffer-
independent binding enthalpy and the net number of exchanged protons upon complex formation.
Figure 4. NTD-MBD-ID interaction with dsDNA. (A,B) Calorimetric titrations of NTD-MBD-ID interacting 
with dsDNA in Tris 50 mM, pH 7, 20 °C. The upper plots show the thermogram (thermal power as a function of 
time), whereas the lower plots show the binding isotherm (normalized heats as a function of the dsDNA/protein 
molar ratio). (C) Experiments at different temperatures provided an estimation of the binding heat capacities. 
(D) Experiments using buffers with different ionization enthalpy provided an estimation of the buffer-
independent binding enthalpy and the net number of exchanged protons upon complex formation.
www.nature.com/scientificreports/
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calorimetric titrations, using a model-free formalism considering two binding sites, indicated that both binding 
sites are different and independent34. This is a remarkable finding, provided that the ability of ID and MBD-ID 
to bind dsDNA was reported before12, but it was not established whether both binding sites would interact with 
the same dsDNA fragment or each domain would interact with an independent dsDNA fragment. Therefore, 
this work represents, to our knowledge, the first experimental evidence for two distinct, independent functional 
dsDNA binding sites in MBD-ID able to interact simultaneously with two independent dsDNA fragments. The 
presence of an additional dsDNA binding site is connected with the much larger dsDNA-induced stabilization 
effect observed on NTD-MBD-ID, compared to the stabilization effects on the other constructs (Fig. 1, Table 1).
The MBD binding site in the NTD-MBD-ID construct showed very high affinity (in the subnanomolar range) 
and a huge favorable binding enthalpy, with no net proton exchange (Table 2). This enthalpically driven binding 
was characterized by a large entropy loss that might reflect a large conformational reorganization upon dsDNA 
binding. On the other hand, the ID binding site showed lower affinity (in the submicromolar range) with favora-
ble enthalpic and entropic contributions, and accompanied by a net proton release upon binding. Both binding 
sites exhibited a large, negative binding heat capacity. Interestingly, the binding heat capacity for the MBD binding 
site was much larger than that for the ID binding site, very likely reflecting a significant conformational rear-
rangement associated to the MBD binding (see Supplementary Fig. S2). In addition, the binding heat capacity 
for mCpG-dsDNA binding to MBD was a bit smaller than that for the binding of unmethylated dsDNA, but the 
binding heat capacity for mCpG-dsDNA binding to ID was similar to that of unmethylated dsDNA. Moreover, 
both MBD and ID sites display a slight higher selectivity (4-fold higher affinity) for mCpG-dsDNA.
Discussion
Structural stability of MBD. The Tm for MBD is rather low, as well as the unfolding enthalpy, indicating a mod-
erate-to-low structural stability. In particular, an unfolding Gibbs energy (or stabilization energy) of 1.4 kcal/mol 
at 20 °C can be calculated from the values in Table 1, corresponding to a molar fraction of 8% unfolded protein. 
The reasoning underlying the selection of 20 °C as the reference temperature for the calorimetric titrations was 
straightforward: to keep a small percentage of unfolded protein, and to compare with a large body of published 
works on protein-DNA interactions studied by ITC. On the other hand, given the length of the dsDNA (45 bp), 
the stabilization energy of dsDNA is much larger than that of the protein. Thermal denaturation experiments per-
formed with isolated dsDNA did not show unfolding of the dsDNA (hyperchromic effect) along the temperature 
range employed.
The estimation of the unfolding heat capacity as an adjustable parameter within the two-state unfolding model 
fitting analysis through spectroscopic denaturations is often not very reliable. However, it can be estimated as the 
slope in an enthalpy vs. temperature plot from a set of {Tm, Δ H(Tm)} pairs determined under slightly different 
conditions. Then, from the results in Table 1 an approximate value of 0.4 ± 0.3 kcal/K·mol is obtained for the 
unfolding heat capacity, which is reasonably close to the one employed in the data analysis.
The unfolding enthalpy provides an indication of the folding cooperativity and an indirect measurement of 
the amount of structured residues in the native conformation. Although with a large variability, it has been shown 
that the unfolding enthalpy at 60 °C, Δ H(60 °C), and 100 °C, Δ H(100 °C), of structured proteins correlate signif-
icantly well with the number of residues (R2 is 0.77 and 0.92, respectively)30. Thus, from the number of residues 
in MBD the expected Δ H(60 °C) and Δ H(100 °C) values are 60 and 110 kcal/mol, respectively; however, from 
the values in Table 1 the extrapolated Δ H(60 °C) and Δ H(100 °C) values are 40 and 60 kcal/mol. Therefore, the 
measured unfolding enthalpy is much smaller than the expected for a structured protein with the same molecular 
mass, and we may conclude that only 60% of MBD is structured, in complete agreement with previous experi-
mental and computational results12,28.
Interaction of MBD with dsDNA. From the experimentally determined thermodynamic profile for the 
MBD-dsDNA interaction (entropically driven binding, unfavorable binding enthalpy, large and negative binding 
heat capacity), it would be reasonable to expect that hydrophobic interactions are predominant. However, the 
binding interface between MBD and dsDNA is mostly of polar nature, with a majority of basic ionizable groups 
(Supplementary Fig. S5). It was noticed before that, in general, proteins binding to the major groove exhibit an 
enthalpically driven binding, whereas those proteins binding to the minor groove exhibit an entropically driven 
binding35. However, MBD binds to the major groove, but its binding is entropically driven, with a slightly unfa-
vorable binding enthalpy.
This thermodynamic binding profile for the MBD-dsDNA interaction is surprising for a number of reasons. 
The interaction interface between MBD and dsDNA is mostly polar (Supplementary Fig. S5) and specific polar 
interactions (hydrogen bonds, electrostatic interactions) are expected to be structurally and energetically pre-
dominant, which would result in a favorable binding enthalpy. Moreover, from the crystallographic structure 
of the MBD-dsDNA complex, the binding interaction results in the burial of 796 Å2 and 429 Å2 of polar and 
non-polar solvent-accessible surface area (SASA), that is, 65% and 35% of the total buried surface, respectively, 
and, therefore, desolvation upon binding mainly leads to the burial of polar surface area, which would result in a 
small, negative binding heat capacity. Moreover, being MBD largely disordered, a large conformational entropy 
penalty stemming from partial conformational rearrangement, which, together with a small desolvation entropy 
contribution derived from a very small non-polar surface desolvation, would lead to an unfavorable binding 
entropy. However, there are some observations supporting the unusual thermodynamic binding profile found 
for the MBD-dsDNA interaction. First, the alignment of the free-dsDNA and dsDNA-bound conformations of 
MBD indicates a very small conformational rearrangement (RMSD around 2 Å, either for all-atoms or α -carbon 
alignments) (Fig. 5). Second, disordered regions in MBD do not appear restructured in the dsDNA complex 
and do not refold upon interaction with dsDNA; in fact, several residues are missing in the crystallographic 
structure, with respect to the crystallized MBD, indicating those residues remain disordered and little refolding 
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is occurring upon dsDNA binding. Therefore, the conformational entropic penalty should be rather small. Third, 
the burial of polar surface upon binding is not necessarily associated with a favorable binding enthalpy, because, 
if hydrogen bonds are not correctly established, the large enthalpic penalty coming from the desolvation of polar 
groups would contribute to an unfavorable binding enthalpy36. And fourth, there is a cluster of water molecules 
sequestered upon dsDNA binding and trapped in the MBD-dsDNA interface. These water molecules, involved 
in a hydrogen bond network between MBD and dsDNA, are highly restricted in a polar interface14 and they may 
contribute to a large, negative binding heat capacity (Fig. 5).
The interaction of MBD with dsDNA is characterized by a very small, unfavorable binding enthalpy. Thus, 
titrations performed using a buffer with a small ionization enthalpy (e.g. phosphate) are characterized by a small 
observed binding enthalpy, whereas titrations performed using a buffer with a large ionization enthalpy (e.g. 
Tris) are characterized by a large observed binding enthalpy. Then, the interaction of MBD with dsDNA is a 
nice example where the signal from the ligand binding becomes amplified through the beneficial coupling with 
the buffer protonation. It is important to emphasize that, provided that all precautions are taken, there are no 
bad buffers in isothermal titration calorimetry, and buffers with small and large ionization enthalpies are com-
monly employed for performing calorimetric titrations. Buffers with large ionization enthalpy may strongly 
contribute to the observed binding enthalpy, but that contribution can be conveniently removed for estimating 
the buffer-independent binding enthalpy and additional information can be obtained (e.g., Δ nH); moreover, the 
buffer contribution may compete with the intrinsic ligand binding enthalpy decreasing the observed signal or 
may amplify the observed signal. In addition (see Supplementary Information), the influence0 of the buffer on 
the determination of the ligand binding heat capacity is not negligible, but it is similar for Tris and phosphate 
(buffers with different ionization enthalpies and ionization heat capacities). Regarding the binding affinity, it is 
not affected by the buffer employed as long as the pKa of the buffer is close to the experimental pH.
As it was observed previously, MBD exhibits low specificity regarding DNA methylation, since the binding 
affinity for mCpG-dsDNA is just 2-fold larger than that for unmethylated dsDNA and the binding enthalpy is very 
similar. However, significantly different stabilization effects are observed for methylated and unmethylated DNA 
(Δ Tm of 10 °C and 18 °C, respectively). These stabilization effects are much larger than those reported before12,28, 
but differences in the experimental pH and ionic strength may introduce differential effects. In addition, the stabi-
lization effects reported here are not in agreement with the small binding affinity differences between mCpG- and 
unmethylated dsDNA, nor with the actual values of the dissociation constants. Because kinetic effects and slow 
assembly reorganization may play an important role (in a calorimetric titration we are observing the transient 
binding within the initial contact when a ligand approaches the receptor binding sites, but in a spectroscopic titra-
tion or in an unfolding assay we are observing the steady state binding after final accommodation of the ligand 
inside the receptor binding site), we are currently working on this issue.
The formation of the MBD-dsDNA complex is accompanied by the net release of about 2 protons. This strong 
pH dependency of the binding affinity (see equation (9), Methods) indicates that, in the vicinity of pH 7, a change 
in ± 1 pH unit will increase/decrease the dissociation constant in a factor of 100. Those protons are dissociated 
from ionizable groups, belonging to MBD or dsDNA, undergoing a pKa reduction upon dsDNA binding. Because 
MBD does not contain cysteines and histidines, and the pKa of phosphates in the dsDNA is about 2, the only 
possible candidates are basic polar groups (tyrosines, arginines, and lysines) and acidic polar groups (aspar-
tates and glutamates) (Supplementary Fig. S6). All these ionizable groups possess pKa values quite far from the 
Figure 5. Conformational and hydration contributions to the MBD-dsDNA interaction. (A) Structural 
alignment of the structure of MBD in solution determined by NMR and the structure of MBD bound to mCpG-
dsDNA determined by X-ray crystallography. (B) Network of hydrogen-bonding water molecules trapped in 
the MBD-dsDNA interaction interface. Water molecules at less than 4 Å simultaneously from both MBD and 
dsDNA are shown as spheres. Methyl-cytidines are shown in orange. (C) Buried hydrogen-bonding water 
molecules in the MBD-dsDNA complex. Water molecules with less than 2 Å2 of SASA are shown as spheres 
(SASA values were calculated with Surface Racer70). Most of the water molecules shown are completely buried 
(SASA = 0 Å2). Methyl-cytidines are shown in orange.
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experimental pH and they would experience a pKa reduction associated with the observed protons release only 
if their pKa in the unbound state is abnormally low (for basic groups) or high (for acidic groups) and/or the pKa 
change is very large. Thus, the identification of the ionizable groups directly involved in the proton exchange pro-
cess is a matter of further work. However, importantly, the analysis of the calorimetric titrations performed using 
different buffers allowed the estimation of the buffer-independent binding parameters.
Calorimetric titrations performed at high ionic strength (NaCl 150 mM) showed a marked reduction in bind-
ing affinity (> 1000-fold reduction) and could not be reliably determined (Supplementary Fig. S4), indicating 
that the formation of the MBD-dsDNA complex is coupled to the net release of salt ions. This diminished bind-
ing affinity is in agreement with the observed small dsDNA-induced stabilization effect in MBD at high ionic 
strength12. Additional calorimetric titrations performed under osmotic stress (glycerol 25%) showed a decrease 
in dsDNA binding affinity (4-fold reduction for mCpG-dsDNA and 2-fold reduction for unmethylated dsDNA) 
(Supplementary Fig. S4). Considering the following relationship37:
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it can be estimated that the affinity loss caused by a reduction in water activity reflects the net uptake of water 
molecules (Δ nw around 20 and 10 molecules for mCpG-dsDNA and unmethylated DNA, respectively) upon 
formation of the MBD-dsDNA complex. It is obvious that this must be a rather approximate number of water 
molecules (mostly associated with preferential hydration), since not all of them will undergo the same configura-
tional constraint upon dsDNA binding.
Influence of MBD-flanking domains. The behavior of the variants (NTD-MBD and NTD-MBD-ID) 
regarding their structural stability and the stabilizing effect of dsDNA binding is similar to that of MBD (Tables 1 
and 2). In addition, the agreement with the previously published results is much better12,28, suggesting that the 
effect of the pH and ionic strength is much smaller for these variants.
It has been previously shown that, contrary to the results reported here, the addition of NTD and ID domains 
lowers the structural stability of MBD12. However, in those reported studies slightly different experimental con-
ditions were employed (pH 7.4 and NaCl 150 mM). The different pH should not be responsible for the disagree-
ment, since we observe a stabilization effect of the flanking domains in the pH range from 7 to 9. Therefore, the 
key factor must be the low ionic strength employed in our experiments. In a highly polar, basic protein, as MBD 
and its variants, the high ionic strength may screen specific and unspecific effects of the flanking disordered 
domains, resulting in a diminished stabilization effect.
The addition of the ID introduces a second dsDNA binding site, and, very important, it also dramatically 
enhances (400-fold) the affinity of the dsDNA-MBD interaction (Table 2, Fig. 4). As it has been mentioned above, 
the dsDNA binding capability of the ID is already known12, but it was not established whether MBD and ID 
would bind to the same dsDNA fragments or they would be able to bind two independent dsDNA fragments. 
Here two inflection points could be observed in the titrations with NTD-MBD-ID and it can be concluded that 
each domain can bind a different and independent dsDNA molecule (that is, MBD and ID do not interact with 
the same dsDNA molecule), which is an important finding supporting MeCP2 function as a chromatin archi-
tecture remodeling, dsDNA looping element, as well as its ability to interact with nucleosomes replacing histone 
H120,38,39. The increase in binding affinity observed for MBD in the presence of ID indicates some kind of struc-
tural and energetic coupling between both domains.
The more plausible interpretation of the two binding sites observed in NTD-MBD-ID is that the high affinity 
site is located in MBD and the low affinity site is located in ID. This is consistent with: 1) submicromolar DNA 
affinity for isolated MBD and NTD-MBD; and 2) the DNA binding affinities reported for isolated MBD and iso-
lated ID in a previous publication (higher affinity for MBD)12. On the other hand, preliminary data in our labo-
ratory from MBD and NTD-MBD-ID variants carrying mutations located in MBD associated with RTT (R106W 
and R133C) show there is a dramatic change in the thermodynamic parameters associated with the binding site 
with higher affinity, while the binding site with lower affinity is hardly affected (data not shown). Because these 
mutations are located in MBD and the high affinity site is the only one affected, the high affinity site should cor-
respond to MBD.
The isolated MBD interacted with dsDNA through an entropically-driven process with a small and unfavora-
ble binding enthalpy; however, the MBD in the presence of ID showed a highly exothermic enthalpically-driven 
dsDNA binding with two large opposing enthalpic and entropic contributions (Table 2, Fig. 4), indicating that 
the mode of interaction for MBD with dsDNA is quite different depending on the MBD structural context. 
Substantial differences in the enthalpy-entropy partition of the Gibbs energy of binding have been linked to very 
different conformational changes, as well as allosteric effects, associated with the binding process40–43.
The two binding sites in NTD-MBD-ID showed significantly different binding affinities and enthalpies. While 
the ID binding site showed favorable enthalpic and entropic contributions, the MBD binding site showed an 
enthalpically driven binding with a considerable entropy loss, suggesting a large conformational change coupled 
to dsDNA binding. Regarding the binding heat capacity, the MBD binding site showed a very large negative 
value in all variants (with a more negative value for unmethylated dsDNA). Importantly, the MBD binding site 
in NTD-MBD-ID showed the largest binding heat capacity, very likely having a significant contribution from a 
conformational rearrangement coupled to dsDNA binding, while the ID binding site showed a smaller negative 
value (with a similar value for mCpG-dsDNA and unmethylated DNA) (Table 2). It has been reported that the 
isolated MBD undergoes a very small conformational rearrangement upon dsDNA interaction (from 60% to 66% 
in secondary structure), while the isolated ID shows a larger conformational rearrangement (from 38% to 59% 
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in secondary structure)12. Therefore, the presence of the ID strongly affects, structurally and energetically, the 
dsDNA interaction at the MBD binding site.
In the NTD-MBD-ID the MBD binding site showed no net proton exchange upon dsDNA binding, whereas 
the ID biding site showed a net release of protons upon dsDNA binding. The interaction of dsDNA with 
NTD-MBD-ID also showed a polyelectrolyte effect. Similar to MBD interaction, the formation of the complex 
is coupled to the release of salt ions, and increasing the concentration of NaCl to 150 mM causes a ∼ 1000-fold 
reduction in the binding affinity. However, because the high affinity binding site has a dissociation constant in 
the subnanomolar range at low ionic strength (Table 2), the protein-dsDNA complex has a dissociation constant 
in the submicromolar range at high ionic strength and the binding affinity is still reliably determined by ITC 
(Supplementary Fig. S4).
Water molecules involved in the MBD-dsDNA interaction. The large, negative binding heat capac-
ity values associated with dsDNA binding deserve special attention, considering that, as already discussed, the 
binding interface is mostly polar and the dsDNA elicits very small conformational rearrangements. The observed 
binding heat capacity can be split into different contributions, each one stemming from any equilibrium coupled 
to dsDNA binding (see Supplementary Information). As explained in detail in the Supplementary Information, 
most of these contributions to the observed heat capacity are smaller than − 0.2 kcal/K·mol and, therefore, they 
cannot explain the large, negative overall binding heat capacities (Table 2). There is an additional source for large 
negative heat capacities that is related to the early observation of a cluster of networking water molecules trapped 
within the MBD-dsDNA binding interface in the crystallographic structure14. Related to this observation, as 
indicated above, calorimetric titrations under osmotic stress suggest there is a net uptake of water molecules upon 
dsDNA binding. These water molecules located in an ordered environment establish hydrogen bonds between 
them, as well as between polar groups in the MBD and the dsDNA (Supplementary Fig. S7), and their highly 
restricted vibrational, librational and rotational modes lead to a reduction in their degrees of freedom associated 
which results in a large decrease in the heat capacity44–48. It has been estimated that a water molecule trapped 
within a polar protein-DNA interface may be associated to a reduction of up to − 0.06 kcal/K·mol in the heat 
capacity. About 16 water molecules can be found at the binding interface between MBD and mCpG-dsDNA, at 
less than 4 Å from simultaneously both MBD and mCpG-dsDNA (Fig. 5). This value is very close to the value 
(20 water molecules) obtained from osmotic stress assays, and the difference could be due to additional loosely 
bound water molecules associated with the complex. Therefore, the local density of water molecules at the bind-
ing interface is 13 molecules/1000 Å2, larger than the average number for protein-protein interfaces (10 water 
molecules/1000 Å2) and similar to other protein-DNA interface49. It is intriguing that the interaction of MBD with 
unmethylated dsDNA is associated with a binding heat capacity slightly larger than that for mCpG-dsDNA, while 
the binding of unmethylated dsDNA seems to be coupled to the uptake of fewer water molecules.
Conclusions
MeCP2 is a multifunctional protein involved in gene regulation and chromatin remodeling that specifically binds 
DNA and other protein partners. Most of the protein remains disordered under physiological conditions and that 
plasticity represents the structural and energetic basis for its multifunctional character. The structural and func-
tional role of disordered regions is not obvious. However, the importance of those disordered regions becomes 
evident bearing in mind that some key mutations associated to RTT are located within those disordered regions. 
Clinically-relevant mutations in MeCP2 may alter its ability to fold and/or to interact properly with DNA or other 
proteins.
We have carried out the first comprehensive calorimetric study of MBD interacting with dsDNA. Additionally, 
we have performed a detailed characterization of different constructs including the N-terminal domain (NTD) 
and the intervening domain (ID) in order to shed light into the structural and functional role of these domains. 
We have assessed their contribution to the global stability and the interaction with dsDNA. From these results 
several important conclusions can be drawn:
•	 The inclusion of both disordered domains increases the structural stability and the folding cooperativity at 
low ionic strength.
•	 MBD and NTD-MBD possesses a single dsDNA binding site with moderate affinity (submicromolar disso-
ciation constant), whereas NTD-MBD-ID possesses two dsDNA binding sites: a high affinity site (subnano-
molar dissociation constant) and a moderate affinity binding site (submicromolar dissociation constant). To 
our knowledge, this is the first experimental evidence for two distinct and independent functional dsDNA 
binding sites in MBD-ID. Thus, NTD-MBD-ID is able to simultaneously attach two independent dsDNA 
fragments and this capability is part of the structural and energetic basis for MeCP2 involvement in chroma-
tin architecture remodeling, looping activity and nucleosome interaction substituting histone H1.
•	 The thermodynamic profile for the interaction of MBD with dsDNA is remarkably unusual for a dsDNA 
major groove-binding protein. While MBD is significantly disordered and its interaction with DNA is medi-
ated by polar residues, the interaction is entropically driven, characterized by a large negative binding heat 
capacity, and coupled to the release of protons and salt ions upon complex formation (heterotropic negative 
cooperativity).
•	 The inclusion of both domains, NTD and ID, increases the affinity of binding to CpG-methylated and 
unmethylated DNA. Because they also increase the stability of the dsDNA-free protein, the impact of both 
flanking domains on the stabilizing effect of CpG-methylated and unmethylated DNA is accumulative.
•	 The affinity enhancing effect of ID on the MBD binding site is considerably larger (> 400-fold) compared to 
that exerted by NTD (3-fold).
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•	 The presence of the ID alters dramatically the thermodynamic profile of the MBD binding site: while the 
isolated MBD shows an entropically-driven moderate binding affinity, the MBD within the NTD-MBD-ID 
construct shows an overwhelmingly enthalpically-driven high binding affinity.
•	 Both dsDNA binding sites in NTD-MBD-ID show markedly different thermodynamic profiles. In particular, 
the MBD site shows a high affinity interaction driven by a very large enthalpic contribution, whereas the ID 
site shows a moderate affinity interaction with favorable enthalpic and entropic contributions. Both binding 
sites exhibit a moderate selectivity for methylated dsDNA.
•	 The very large favorable binding enthalpy, the unfavorable binding entropy, and the very large binding heat 
capacity for the MBD binding site in the NTD-MBD-ID variant suggest a significant conformational rear-
rangement is coupled to the interaction with dsDNA.
•	 The observed large, negative binding heat capacity cannot be explained on the basis of the solvent-accessible 
surface area burial upon dsDNA binding. Moreover, the consideration of conformational changes (except for 
the NTD-MBD-ID variant, which very likely undergoes a significant conformational rearrangement upon 
dsDNA binding) and additional binding equilibria (protons and salt ions exchange) coupled to DNA bind-
ing do not justify the large binding heat capacity value. The network of hydrogen-bonded water molecules 
trapped between the protein and the dsDNA seems to be responsible for most of the large, negative binding 
heat capacity.
As a corollary from these conclusions, it can be established that the structural and functional properties of 
MBD from MeCP2 are dependent on the context. NTD and ID domains seem to play an important structural 
and functional role in MeCP2, and this adds to the rationale for its multifunctional nature, as well as the impact 
of mutations located within disordered regions. Therefore, intrinsic factors (presence of flanking domains, and 
dynamics and mobility of disordered regions), as well as extrinsic factors (ionic concentration and water mole-
cules), strongly modulate the global structural properties and functional capabilities of MeCP2.
The key role of water molecules involved in the mCpG-dsDNA recognition by MBD has been postulated to 
be a general mechanism associated with mCpG recognition50, and, thus, the thermodynamic signature found 
for MeCP2 MBD should be a common general feature among mCpG recognition proteins. It is increasingly 
apparent that water is not just a passive matrix were physiological reactions take place, but water molecules are 
key active elements in many biomolecular processes such as protein folding51,52, nucleic acid assembly53, enzyme 
catalysis54, and molecular recognition55–60. In particular, waters at the interfaces of protein-DNA complexes may 
maintain packing density, screen electrostatic repulsions between charges, and act as linkers between comple-
mentary charges on the biomolecules61. Therefore, the thermodynamic profile of the binding energetics of a given 
interaction may be strongly affected by the active involvement of water molecules and it may contain a significant 
contribution from unusual hydration patterns.
There are some questions that must be addressed in future work: What are the structural roles of the other 
MeCP2 domains? How do they affect the structural and functional properties of MeCP2? What is the effect of 
mutations associated with RTT, located in structured or disordered regions, on the structural and functional 
properties of MeCP2? Why does unmethylated dsDNA induce a smaller stabilization effect on MBD while its 
thermodynamic binding profile is similar to that of mCpG-dsDNA? Given the larger binding heat capacity for 
unmethylated dsDNA binding, are water molecules also mediating that interaction? What are the thermody-
namic binding parameters of isolated ID interacting with mCpG- and unmethylated dsDNA?
Methods
Plasmid construction. MBD and full-length human MeCP2 (isoform 2) were inserted in a pET30b plas-
mid for protein expression. The different protein variants were obtained by inserting appropriate stop codons: 
NTD-MBD and NTD-MBD-ID (Supplementary Fig. S1). The protein sequences contained an N-terminal poly-
histidine-tag which was always removed after purification through an inserted PreScission Protease recognition 
cleavage site. All sequences were checked by sequencing analysis. The protein variants were checked and corrob-
orated by Sanger sequencing using a BigDye Terminator v3.1 Cycle Sequencing Kit (Life Technologies, Carlsbad, 
CA) in an Applied Biosystems 3730/DNA Analyzer (Thermo Fisher Scientific, Waltham, MA). The data were 
analyzed with BioEdit Sequence Alignment Editor62.
Protein expression and purification. All three protein variants (MBD, NTD-MBD and NTD-MBD-ID) 
were expressed and purified following the same procedure. Plasmids were transformed into BL21 (DE3) Star 
E. coli strain. Bacteria cultures were grown in 150 mL of LB/kanamycin (50 μ g/mL) media at 37 °C overnight. 
Then, 4 L of LB/kanamycin (25 μ g/mL) were inoculated (1:100 dilution) and incubated under the same conditions 
until reaching an OD (at a wavelength of 600 nm) of 0.6. Protein expression was induced with 1 mM isopropyl 
1-thio-β -D-galactopyranoside (IPTG) at 18 °C overnight. Cells were ruptured by sonication in ice and benzo-
nase (Merck-Millipore, Madrid, Spain) was added (20 U/mL) to remove nucleic acids. Proteins were purified 
using immobilized metal ion affinity chromatography (IMAC) in a HiTrap TALON column (GE-Healthcare Life 
Sciences, Barcelona, Spain) with two washing steps: buffer sodium phosphate 50 mM, pH 7, NaCl 300 mM, and 
in buffer sodium phosphate 50 mM, pH 7, NaCl 800 mM (to remove potential DNA contamination from the pro-
tein), before an imidazole 10–150 mM elution gradient. Purity was checked by SDS-PAGE.
Removal of the histidine-tag was performed by GST-tagged PreScission Protease processing in cleavage buffer 
(50 mM Tris-HCl, 150 mM NaCl, pH 7.5) at 4 °C for 4 hours. Progress of the protease processing was checked by 
SDS-PAGE. Finally, proteins were further purified using a combination of two affinity chromatographic steps to 
remove the histidine-tag (HiTrap TALON column, from GE-Healthcare Life Sciences, Barcelona, Spain) and the 
GST-tagged PreScission Protease (GST TALON column, from GE-Healthcare Life Sciences, Barcelona, Spain). 
Purity and homogeneity were checked by SDS-PAGE and size-exclusion chromatography. The proteins were 
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stored in buffer Tris 50 mM pH 7.0 at − 80 °C. The identity of all proteins was checked by mass spectrometry 
(4800plus MALDI-TOF/MS, from Applied Biosystems - Thermo Fisher Scientific, Waltham, MA). Potential DNA 
contamination was always checked determining the ration of UV absorption at 260 nm vs absorption at 280 nm. 
An extinction coefficient of 11460 M−1 cm−1 at 280 nm was employed for MBD and the variants.
Stability and binding assays were performed at different pH and buffer conditions (Tris 50 mM pH 7–9, NaCl 
0–150 mM; Pipes 50 mM, pH 7; Phosphate 50 mM, pH 7). When needed, buffer exchange was performed using 
a 3 or 10 kDa-pore size ultrafiltration device (Amicon centrifugal filter, Merck-Millipore) at 4000 rpm and 4 °C.
Double-stranded DNA. HPLC-purified methylated and unmethylated 45-bp single-stranded DNA (ssDNA) 
oligomers corresponding to the promoter IV of the mouse brain-derived neurotrophic factor (BDNF) gene12,28 
were obtained from Integrated DNA Technologies. Two complementary pairs of DNA were used for DNA binding 
assays: forward unmethylated: 5′ -GCCATGCCCTGGAACGGAACTCTCCTAATAAAAG-ATGTATCATTT-3′ ; 
reverse unmethylated: 5′ -AAATGATACATCTTTTATTAGGAGAGTTCCGTTCC-AGGGCATGGC-3′ ; forward 
mCpG: 5′ -GCCATGCCCTGGAA(5-Me)CGGAACTCTCCTAATAAA-AGATGTATCATTT-3′ ; reverse mCpG: 
5′ -AAATGATACATCTTTTATTAGGAGAGTTC(5-Me)CGTT-CCAGGGCATGGC-3′ .
The DNA fragments were purchased as ssDNA oligonucleotides and they were subsequently annealed to 
obtain 45-bp double-stranded DNA (dsDNA) for the interaction experiments. Briefly, they were dissolved to 
obtain a 0.5 mM ssDNA solution for each oligonucleotide; then, they were mixed at an equimolar ratio and were 
annealed using a Stratagene Mx3005 P qPCR real-time thermal cycler (Agilent Technologies, Santa Clara, CA). 
The thermal annealing profile consisted of: 1) equilibration at 25 °C for 30 s; 2) heating ramp up to 99 °C; 3) equi-
libration at 99 °C for 60 s; and 4) 3-hour cooling process down to 25 °C at a rate of 1 °C/180 s.
Circular dichroism. Circular dichroism spectra were recorded in a thermostated Chirascan spectrom-
eter (Applied Photophysics, Leatherhead, UK) using a 0.1 cm path-length quartz cuvette (Hellma Analytics, 
Müllheim, Germany) with a bandwidth of 1 nm, an spectral resolution of 0.5 nm, and a response time of 5 s. 
Temperature was controlled by a Peltier unit and monitored using a temperature probe. The assays were per-
formed in the far-UV range (190–260 nm). Protein concentration was set at 10–50 μ M.
The poor signal related to the low content in secondary structure of the proteins and its small change during 
the thermal denaturation process within the temperature range 10–90 °C favored the use of fluorescence spectros-
copy in the thermal unfolding assays.
Fluorescence spectroscopy. Thermal unfolding studies were performed in a Cary Eclipse fluorescence 
spectrophotometer (Varian – Agilent, Santa Clara, CA) in three steps using a 1 cm path-length quartz cuvette 
(Hellma Analytics, Müllheim, Germany). Temperature was controlled by a Peltier unit and monitored using a 
temperature probe. Fluorescence emission spectra were recorded from 300 to 400 nm using an excitation wave-
length of 290 nm and a bandwidth of 5 nm. Protein concentration was set at 5 μ M.
Thermal stability assays were performed at a heating rate of 1 °C/min and at the wavelength for maximal spec-
tral change. Thermal unfolding experiments were analyzed considering a two-state unfolding model:
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where F is the fluorescence signal, T is the absolute temperature, Tm is the midtransition temperature, Δ H(Tm) is 
the unfolding enthalpy, Δ CP is the unfolding heat capacity, and Δ G is the stabilization Gibbs energy. The adjusta-
ble parameters AN, BN, AU, and BU define the pre- (native) and post-transition (unfolded) regions. This model can 
be applied to protein with low stability where the population of native protein is lower than 1 even at low temper-
ature (that is, the straight line AN+ BNT does not coincide with the observed signal), because the linear pre- and 
post-transition trends are fitted within the non-linear regression analysis procedure. The stabilizing effect upon 
dsDNA interaction was assessed performing thermal denaturations of the different proteins (at 5 μ M) in the pres-
ence of methylated and unmethylated DNA (at 10 μ M) under the same conditions.
Isothermal titration calorimetry (ITC). The interaction between the different proteins and dsDNA was 
characterized using an Auto-iTC200 microcalorimeter (MicroCal – Malvern Instruments, Malvern, UK). Protein 
in the calorimetric cell at 3–5 μ M was titrated with dsDNA at 50 μ M. All solutions were degassed at 15 °C for 2 min 
before each assay. A sequence of 2 μ L-injections of titrant solution every 150 s was programmed and the stirring 
speed was set to 750 rpm. The association constant, KB,obs, and the enthalpy of binding, Δ Hobs, were estimated 
through non-linear regression of the experimental data employing a single ligand binding site model (1:1 pro-
tein:dsDNA stoichiometry) or a two ligand binding sites model (1:2 protein:dsDNA stoichiometry) implemented 
in Origin (OriginLab, Northampton, MA)34,63.
Titrations were performed at different temperatures (15, 17.5 and 20 °C) in order to estimate the observed 
binding heat capacity change, Δ CP,obs:
∆ =



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∂

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H
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P obs
obs
P
,
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which is a parameter directly reflecting changes in solvent-exposed molecular surface upon protein-DNA com-
plex formation and, therefore, it reflects conformational rearrangements coupled to binding. However, any 
equilibrium (e.g., ion release/uptake) coupled to ligand binding may contribute to the observed binding heat 
capacity. The narrow temperature range employed was appropriate, because the observed heat capacity change 
was remarkably large.
When ligand binding is coupled to proton exchange, the association binding constant, KB, is not affected by 
the buffer ionization as long as the pKa of the buffer is close to the experimental pH, but it is influenced by the pH 
and the proton dissociation constants, pKa, of certain ionizable groups31,64:
= ∏
+
∏ +
=
−
=
−
K K (1 10 )
(1 10 ) (7)
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1
a i
C
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,
where KB is the association constant for fully deprotonated reactants (at sufficiently high pH), m is the number of 
ionizable groups involved in the proton exchange (that is, those groups undergoing a pKa change as a result of the 
complex formation), and pKaF and pKaC are the pKa values for those ionizable groups in the free and the complex 
state. However, the observed binding enthalpy (and, therefore, the entropic contribution also) will contain an 
additional contribution from buffer ionization properties. In particular64–66:
∆ = ∆ + ∆ ∆H H n H (8)obs H buffer
where Δ H is the buffer-independent enthalpy, Δ Hbuffer is the ionization enthalpy of the buffer, and Δ nH is the net 
number of exchanged protons between the protein-DNA complex and the bulk solution upon complex forma-
tion, which can be calculated as follows:
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Thus, Δ nH also indicates the change in binding affinity as a result of a change in pH. Titrations were performed in buff-
ers with different ionization enthalpies (Tris, 11.35 kcal/mol; Pipes, 2.67 kcal/mol; and phosphate, 0.86 kcal/mol)67  
in order to estimate the buffer-independent thermodynamic parameters (Δ H and Δ nH) from linear regression 
using equation (8).
Analytical ultracentrifugation (AUC). Sedimentation velocity assays were carried out at 48 krpm in an 
XL-I analytical ultracentrifuge (Beckman Coulter, Barcelona, Spain) equipped with UV-VIS absorbance and 
Raleigh interference detection systems. Sedimentation profiles were recorded at 260 nm. Sedimentation coef-
ficient distributions were calculated by least-squares boundary modelling of sedimentation velocity data using 
the continuous distribution c(s) Lamm equation model as implemented by SEDFIT 14.168. Experimental s values 
were corrected to standard conditions (water, 20 °C, and infinite dilution) using the program SEDNTERP to get 
the corresponding standard s values (s20,w)69.
Reported values always correspond to experimental replicates.
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